4.82 USD
↗ 0.16 (3.43%)AT CLOSE (03:59 PM EST)
CorMedix Inc. (CRMD) trades at $4.81 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a weak Piotroski F-Score of 1/9, exceptional Return on Equity (40.6%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CRMD appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 16, 2026.